← Leaderboards
Athan Kuliopulos
Tufts Medical Center
$25,203,288
Attributed
$25,203,288
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2005–24$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$25,203,288 · 7
By mechanism
R01$13,504,478 · 5
P50$9,999,362 · 1
RC2$1,699,448 · 1
Top collaborators
No co-investigators on record.
Most similar at Tufts Medical Center
Same institution · by research overlap
- Michael E Mendelsohn$8,988,947
- Lidija Covic$1,552,014
- Susan Kenyon Parsons$4,736,216
- Roberta M O'Connor$5,231,388
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsSignal TransductionReceptorThrombinMetalloproteasesBlood VesselsLeadPeptide HydrolasesPar-1 ReceptorBlood PlateletsLifeThrombin ReceptorBaseIn VivoGtp-Binding ProteinsCleaved CellAgonistBlood CoagulationInterstitial CollagenaseInflammationPreventLigandsCell TypeAnimal Model
Grant awards (39)
Metabolic Reprogramming by Protease-activated Receptor 2$567,618
R01 · FY2024 · DK · contact PI
Metabolic Reprogramming by Protease-activated Receptor 2$591,270
R01 · FY2023 · DK · contact PI
Metabolic Reprogramming by Protease-activated Receptor 2$587,400
R01 · FY2022 · DK · contact PI
Matrix Metalloprotease-PAR1 Regulation of Atherosclerosis$646,131
R01 · FY2021 · HL · contact PI
Matrix Metalloprotease-PAR1 Regulation of Atherosclerosis$709,682
R01 · FY2020 · HL · contact PI
Matrix Metalloprotease-PAR1 Regulation of Atherosclerosis$709,682
R01 · FY2019 · HL · contact PI
Matrix Metalloprotease-PAR1 Regulation of Atherosclerosis$726,028
R01 · FY2018 · HL · contact PI
TRIP-PCI: PAR1 Pepducin-Based Interventions in Arterial Thrombosis$1,794,671
P50 · FY2016 · HL · contact PI
TRIP-PCI: PAR1 Pepducin-Based Interventions in Arterial Thrombosis$1,975,189
P50 · FY2015 · HL · contact PI
TRIP-PCI: PAR1 Pepducin-Based Interventions in Arterial Thrombosis$2,013,904
P50 · FY2014 · HL · contact PI
TRIP-PCI: PAR1 Pepducin-Based Interventions in Arterial Thrombosis$2,055,805
P50 · FY2013 · HL · contact PI
TRIP-PCI: PAR1 Pepducin-Based Interventions in Arterial Thrombosis$2,159,793
P50 · FY2012 · HL · contact PI
Thrombin Receptor-G Protein Signaling Mechanisms$402,500
R01 · FY2011 · HL · contact PI
CTRIP: MMP1-PAR1-based Interventions in Arterial Thrombosis$601,043
RC2 · FY2010 · HL · contact PI
Thrombin Receptor-G Protein Signaling Mechanisms$402,500
R01 · FY2010 · HL · contact PI
Protease-activated receptors in vascular integrity and dysfunction$402,500
R01 · FY2010 · HL · contact PI
Inter-Cellular Signaling of Invastion Receptors in the Tumor Microenvironment$305,900
R01 · FY2010 · CA · contact PI
CTRIP: MMP1-PAR1-based Interventions in Arterial Thrombosis$1,098,405
RC2 · FY2009 · HL · contact PI
Protease-activated receptors in vascular integrity and dysfunction$402,500
R01 · FY2009 · HL · contact PI
Thrombin Receptor-G Protein Signaling Mechanisms$402,500
R01 · FY2009 · HL · contact PI
Inter-Cellular Signaling of Invastion Receptors in the Tumor Microenvironment$305,900
R01 · FY2009 · CA · contact PI
Thrombin Receptor-G Protein Signaling Mechanisms$402,500
R01 · FY2008 · HL · contact PI
Protease-activated receptors in vascular integrity and dysfunction$402,500
R01 · FY2008 · HL · contact PI
Inter-Cellular Signaling of Invastion Receptors in the Tumor Microenvironment$305,900
R01 · FY2008 · CA · contact PI
Protease-activated receptors in vascular integrity and dysfunction$402,500
R01 · FY2007 · HL · contact PI
Thrombin Receptor-G Protein Signaling Mechanisms$402,500
R01 · FY2007 · HL · contact PI
Inter-Cellular Signaling of Invastion Receptors in the Tumor Microenvironment$305,900
R01 · FY2007 · CA · contact PI
Mechanism of Thrombin Receptor Activation/Deactivation$355,935
R01 · FY2006 · HL · contact PI
Mechanism of Thrombin Receptor Activation/Deactivation$364,500
R01 · FY2005 · HL
THROMBIN RECEPTOR-G PROTEIN SIGNALING MECHANISMS$355,500
R01 · FY2005 · HL
Mechanism of Thrombin Receptor Activation/Deactivation$364,500
R01 · FY2004 · HL
THROMBIN RECEPTOR-G PROTEIN SIGNALING MECHANISMS$355,500
R01 · FY2004 · HL
Mechanism of Thrombin Receptor Activation/Deactivation$364,500
R01 · FY2003 · HL
THROMBIN RECEPTOR-G PROTEIN SIGNALING MECHANISMS$355,500
R01 · FY2003 · HL
THROMBIN RECEPTOR-G PROTEIN SIGNALING MECHANISMS$355,500
R01 · FY2002 · HL
MECHANISM OF THROMBIN RECEPTOR ACTIVATION/DEACTIVATION$306,722
R01 · FY2002 · HL
THROMBIN RECEPTOR-G PROTEIN SIGNALING MECHANISMS$355,500
R01 · FY2001 · HL
MECHANISM OF THROMBIN RECEPTOR ACTIVATION/DEACTIVATION$297,792
R01 · FY2001 · HL
MECHANISM OF THROMBIN RECEPTOR ACTIVATION/DEACTIVATION$289,118
R01 · FY2000 · HL